26414-90-4

Basic information

• Product Name: 4-Pyridinecarbonitrile, 3-methoxy-
• CAS NO: 26414-90-4
• Molecular Formula: C7H6N2O
• Molecular Weight: 134.137
• Mol File: 26414-90-4.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 4-Pyridinecarbonitrile, 3-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Pyridinecarbonitrile, 3-methoxy-(26414-90-4)
• EPA Substance Registry System: 4-Pyridinecarbonitrile, 3-methoxy-(26414-90-4)

Safety Data

• Hazardous Substances Data: 26414-90-4(Hazardous Substances Data)

Usage

General Description

4-Pyridinecarbonitrile, 3-methoxy- is a chemical compound with the molecular formula C7H6N2O. It is also known as 3-methoxy-4-pyridinecarbonitrile. 4-Pyridinecarbonitrile, 3-methoxy- is widely used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and pharmaceutical products. It is a versatile building block for the preparation of heterocyclic compounds and has applications in the production of anti-inflammatory, anti-cancer, and antiviral drugs. Additionally, this chemical is often utilized as a reagent in organic chemistry reactions, making it an important component in chemical synthesis processes.

Upstream product

• 124-41-4 sodium methylate 
• 68325-15-5 3-chloro-isonicotinonitrile 
• 100-48-1 pyridine-4-carbonitrile 

Downstream Products

• 83431-02-1 1-(3-methoxypyridin-4-yl)-ethanone 
• 654663-32-8 3-methoxypyridine-4-carboxylic acid 

Relevant articles and documents

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.

FUNCTIONALIZED HETROARYL ENONES EXHIBITING NRF2 ACTIVATION AND THEIR METHOD OF USE

Pharmaceutical compositions are disclosed, which include functionalized hetroaryl enones and are useful for treating or preventing a disease, disorder or condition associated with an NRF2-regulated pathway and/or which involves oxidative stress.